1st Quarter - Report

THE OB-C GROUP, LLC for ELI LILLY

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

S 3, Medicare Prescription Drug Price Negotiation Act of 2007: Medicare program. HR 4, Medicare Prescription Drug Price Negotiation Act of 2007: Medicare program. HR 5629, Pathway for Biosimilars Act: biologics. S 1695, Biologics Price Competition and Innovation Act of 2007: biologics.

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 4 (110th), H.R. 5629 (110th)

Copyright/Patent/Trademark CPT

S 1145, Patent Reform Act of 2007: patent reform. HR 1908, Patent Reform Act of 2007: patent reform.

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1908 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.